Copper Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Comparison between two methods of the immediate post-placental insertion of copper intrauterine device in vaginal birth —a protocol for a randomized clinical trial
This study was approved by the Ethics and Research Commission of UNICAMP (CAAE: 50497321.4.0000.5404) and the Brazilian Registry of Clinical Trials (REBEC) (number RBR-4j62jv6). This is the first version of the study protocol approved on 11/12/2021 prior to the start of participant recruitment. (Source: Trials)
Source: Trials - December 27, 2022 Category: Research Source Type: clinical trials

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition
Condition:   Manganese Safety in Adults Interventions:   Drug: Tralement;   Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid Sponsor:   American Regent, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2022 Category: Research Source Type: clinical trials